Commissioner to spell out review action next month
This article was originally published in Clinica
Directorate General Enterprise Commissioner, Erkii Liikanen, will make a statement at the Health Council meeting on June 26, summarising what actions his the medical devices unit will need to take to address the findings of the five-year review of the Medical Devices Directive.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.